Dormant
BILL · BILL Holdings, Inc.
Last analysed ·
Current thesis
BILL Holdings’ margin recovery needs customer stabilisation at the next quarterly report after the September 11 close erased August’s rebound. A weekly close above $52 before a weekly close below $44 would confirm the price-recovery case; first-quarter revenue below the guided $432.5 million floor would contradict its operating explanation.
Kill line
A weekly close below $44 ends the recovery thesis at the research threshold published 2026-08-30; first-quarter fiscal 2027 revenue below the $432.5 million guidance floor or businesses served below 479,300 would separately break the operating case.
Pick status
Open commitment catalyst 4d agoscored if the kill line above fires How this is scored →Latest analysis and events for BILL —
As of 13 September 2026, the latest FrontierPicks analysis for BILL Holdings, Inc. (BILL): BILL Holdings’ margin recovery needs customer stabilisation at the next quarterly report after the September 11 close erased August’s rebound. A weekly close above $52 before a weekly close below $44 would confirm the price-recovery case; first-quarter revenue below the guided $432.5 million floor would contradict its operating explanation.
Kill line: A weekly close below $44 ends the recovery thesis at the research threshold published 2026-08-30; first-quarter fiscal 2027 revenue below the $432.5 million guidance floor or businesses served below 479,300 would separately break the operating case.
Most recent dated event on file: — catalyst 4d ago.
Current Thesis
BILL Holdings’ margin-recovery thesis now depends on customer stabilisation at the next quarterly report, while a weekly close above $52 before a weekly close below $44 would confirm its price recovery. The September 11, 2026 adjusted close of $47.25 was below both the August 28 close of $50.31 and the August 21 post-results close of $47.82. The rebound described on August 30 has therefore reversed; the operating case remains supported by the August 19 results.
BILL reported fiscal fourth-quarter core revenue of $400.5 million, up 16% year over year, and adjusted operating income of $101.6 million, up 80%, on August 19, 2026. The inference is that the narrative is maturing — Truist’s September 1 target increase extended the August analyst coverage, but the September 11 close shows no accompanying price recovery. A weekly close above Truist’s $52 target would challenge that assessment of stalled momentum; the target is an analyst valuation, not demonstrated chart resistance.
Bullish and bearish views on BILL Holdings, Inc.
The model's bull view on BILL Holdings, Inc. (BILL), in brief: Profit growth exceeded revenue growth. BILL’s August 19, 2026 release reported a 23% adjusted operating margin for the fiscal fourth quarter alongside 16% core-revenue growth. These measured results support the margin-recovery argument; a reduction to the fiscal 2027 adjusted… The bear view: Customer contraction remains unresolved. Both cases follow in full.
Bull Case
- Profit growth exceeded revenue growth. BILL’s August 19, 2026 release reported a 23% adjusted operating margin for the fiscal fourth quarter alongside 16% core-revenue growth. These measured results support the margin-recovery argument; a reduction to the fiscal 2027 adjusted operating-income guidance of $421–$451 million would contradict its continuation.
- Cash generation supports corporate repurchases. The fiscal 2026 Form 10-K, filed August 20, 2026, reported operating cash flow of $415.8 million and free cash flow of $354.7 million. The August 19 results disclosed $300 million of company repurchases during the June quarter; that is historical corporate demand, with no evidence here establishing its subsequent pace.
- Analyst support extended into September. Truist maintained Hold and raised its price target to $52 on September 1, 2026. This extends the dated coverage beyond Wolfe Research’s August 25 target of $60, but neither target establishes future demand for the shares. Benzinga analyst actions
Bear Case
- Customer contraction remains unresolved. BILL’s August 19, 2026 results showed 479,300 businesses served at June 30, down sequentially from 493,800 in the fiscal third quarter. Another reading below 479,300 would contradict customer stabilisation.
- Revenue guidance leaves limited reassurance. On August 19, 2026, BILL guided fiscal first-quarter revenue to $432.5–$442.5 million and fiscal 2027 revenue to $1.807–$1.857 billion. First-quarter revenue below $432.5 million or a reduction to the annual range would break the operating case.
- Adjusted earnings obscure continuing losses. The August 19, 2026 release reported a fiscal fourth-quarter net loss under generally accepted accounting principles (GAAP) of $18.5 million alongside adjusted operating income of $101.6 million. The recovery thesis rests on adjusted profitability; that quarter did not establish GAAP profitability.
Setup & Price Structure
The adjusted daily series dated September 11, 2026 records a $47.25 close, a three-month price increase of 42.4%, and a close 16.1% below the $56.31 trailing-year high. The 14-period relative strength index (RSI) was 47.9. The positive three-month change coexists with the loss of the August rebound; it does not establish renewed acceleration.
The $44 research threshold published August 30, 2026 remains the thesis-break condition. The available observations do not establish repeated support tests at that level. A weekly close above $52, the September 1 Truist target, defines the price-recovery outcome before that threshold is breached.
Positioning evidence is limited to dated analyst coverage and the issuer’s disclosed June-quarter repurchases. Current moving-average values, retail participation, short interest and subsequent insider transactions are missing. Those observations cannot support a conclusion about crowding or the breadth of participation.
Catalyst Calendar (next 30 days)
- 2026-10-07 — September meeting minutes. The Federal Reserve schedules publication of the September meeting minutes for October 7. They provide further policy context for the same disclosed interest-income exposure, without resolving BILL’s customer-count question. Federal Reserve monetary-policy schedule
- ~2026-11-05, est. Fiscal first-quarter results. This remains an unconfirmed estimate from the August 30, 2026 published calendar, outside the next month. The report is the operating test: businesses served against 479,300 and revenue against the $432.5 million guidance floor disclosed August 19.
Elapsed catalysts
- 2026-09-16 — Federal Reserve decision. The Federal Open Market Committee (FOMC) meets September 15–16, with updated economic projections scheduled for that meeting. BILL disclosed fiscal 2026 float revenue of $148.4 million on August 19, 2026, making the rate decision relevant to interest earned on customer funds; no direction of the decision is assumed. Federal Reserve calendar (passed 4d ago)
What Would Change Our Mind
Failure of the recovery structure would end the price thesis: a weekly close below $44 breaches the research threshold established August 30, 2026. Customer numbers below the June 30 reading of 479,300, first-quarter revenue below the August 19 guidance floor of $432.5 million, or reduced annual guidance would separately contradict the operating thesis.
Conversely, a weekly close above Truist’s September 1 target of $52 before the $44 condition fires would complete the defined price-recovery case. Customer stabilisation and revenue meeting the disclosed first-quarter range would substantiate its operating explanation. The evidence supports medium conviction: August’s margin improvement is measured, while the September 11 price reversal and June customer decline remain unresolved.
Correlation Notes
This is a single-company margin-recovery case. BILL’s August 19, 2026 disclosure of $98 billion in quarterly total payment volume, up 14% year over year, identifies business-payment activity as an operating exposure. The fiscal 2026 float-revenue disclosure identifies a separate interest-rate exposure.
No paired return series is available to measure correlation with software shares, consumer-credit companies or bond yields. The limited price observations cannot establish those relationships, and no group move is required for the stated thesis.
Notes
- Fiscal year ends June 30. Q4/FY2026 was reported 2026-08-19 after the close; the FY2026 Form 10-K was filed 2026-08-20.
- BILL is B2B SMB financial-operations automation — AP/AR, Divvy spend cards, invoicing. Screens that bucket it with consumer fintech mis-frame the demand driver.
- Float revenue ($148.4M in FY2026) is interest earned on customer funds held, so the front-end rate path moves the P&L independently of software growth.
- Cash and restricted cash of $3.77B at 2026-06-30 largely represents funds held for customers and is not free corporate liquidity.
- GAAP and non-GAAP diverge widely — FY2026 GAAP net loss $11.2M versus non-GAAP net income $314.8M; headline EPS comparisons are non-GAAP.
- The $1.0B repurchase authorization dated 2026-05-07 runs 24 months; open-market execution customarily pauses during pre-earnings blackout windows.
Related · shared themes
DAVE
Dave Inc.
Dave Inc.'s growth-and-credit-quality recovery case is invalidated by the September 18, 2026 weekly close of $337.82 below its published $358 boundary. JPMorgan's September 15 initiation adds favorable coverage but does not reverse that outcome.
SEZL
Sezzle Inc.
Sezzle's profitable-growth recovery thesis requires a daily close above $129.87 before a weekly close below $114 invalidates it. The 2026-09-18 adjusted close of $116.55 lost the August shelf again, reversing the intermediate repair described on September 11.
FBIZ
First Business Financial Services, Inc.
First Business Financial Services’ earnings re-rating depends on Q3 sustaining its 3.78% margin and exceeding $19.8 million in pre-tax pre-provision earnings. The thesis fails on a weekly close below $68 or deterioration below those Q2 operating benchmarks.
OPRT
Oportun Financial Corporation
Oportun Financial Corporation's margin-repair re-rating needs a weekly close above the $8.09 market high and Q3 results meeting its 2026-08-05 guidance. A weekly close below $7.00 or Q3 adjusted EBITDA below $43 million invalidates the case.